alpha-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->4)-beta-D-GalpNAcO[CH2]5NH2

Term ID

CHEBI:140513

Synonyms

5-aminopentyl 2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1->2)-6-deoxy-alpha-L-mannopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-L-galactopyranoside
5-aminopentyl 2-acetamido-2-deoxy-alpha-D-glucopyranosyl-(1->2)-alpha-L-rhamnopyranosyl-(1->4)-2-acetamido-2-deoxy-beta-L-galactopyranoside
5-aminopentyl N-acetyl-alpha-D-glucosaminyl-(1->2)-alpha-L-rhamnosyl-(1->4)-N-acetyl-beta-L-galactosaminide
alpha-D-GlcNAc-(1->2)-alpha-L-Rha-(1->4)-beta-D-GalNAcO[CH2]5NH2
GlcNAcalpha1-2Rhabeta1-4GalNAcbetaO[CH2]5NH2

Definition

A linear trisaccharide derivative consisting of N-acetyl-alpha-D-glucosamine, alpha-L-rhamnose and N-acetyl-beta-D-galactosamine residues linked sequentially (1->2) and (1->4) with the N-acetylgalactosamine residue linked glycosidically to a 5-aminopentyl group.

References

PMID:29333751

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycoside trisaccharide derivative

glycoside trisaccharide derivative Show first 5 Terms

Phenotype

Phenotype resulting from alpha-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->4)-beta-D-GalpNAcO[CH2]5NH2

Phenotype where environments contain alpha-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->4)-beta-D-GalpNAcO[CH2]5NH2

Phenotype modified by environments containing alpha-D-GlcpNAc-(1->2)-alpha-L-Rhap-(1->4)-beta-D-GalpNAcO[CH2]5NH2

Human Disease Model